PharmaEssentia: Announcement of the Company's Board of Directors' Resolution to Acquire 100% Equity of Forus Therapeutics Inc.
NQ Score
65/100
AI Summary (NQ-processed)
PharmaEssentia's board of directors resolved on April 9, 2026, to acquire 100% of Forus Therapeutics Inc.'s equity for CAD 50 million. This acquisition aims to strengthen and expand the company's product presence in the Canadian market. The funding will come from own funds or capital raised through overseas depositary receipts issued in 2023.
AI analysis data is not yet available.